全文获取类型
收费全文 | 1464篇 |
免费 | 165篇 |
国内免费 | 5篇 |
专业分类
耳鼻咽喉 | 6篇 |
儿科学 | 76篇 |
妇产科学 | 33篇 |
基础医学 | 174篇 |
口腔科学 | 49篇 |
临床医学 | 123篇 |
内科学 | 359篇 |
皮肤病学 | 15篇 |
神经病学 | 46篇 |
特种医学 | 260篇 |
外科学 | 126篇 |
综合类 | 18篇 |
一般理论 | 1篇 |
预防医学 | 110篇 |
眼科学 | 9篇 |
药学 | 51篇 |
1篇 | |
中国医学 | 8篇 |
肿瘤学 | 169篇 |
出版年
2021年 | 23篇 |
2020年 | 11篇 |
2018年 | 22篇 |
2017年 | 13篇 |
2016年 | 25篇 |
2015年 | 19篇 |
2014年 | 35篇 |
2013年 | 39篇 |
2012年 | 59篇 |
2011年 | 59篇 |
2010年 | 53篇 |
2009年 | 47篇 |
2008年 | 41篇 |
2007年 | 44篇 |
2006年 | 50篇 |
2005年 | 44篇 |
2004年 | 49篇 |
2003年 | 32篇 |
2002年 | 26篇 |
2001年 | 32篇 |
2000年 | 39篇 |
1999年 | 25篇 |
1998年 | 47篇 |
1997年 | 41篇 |
1996年 | 44篇 |
1995年 | 47篇 |
1994年 | 42篇 |
1993年 | 45篇 |
1992年 | 23篇 |
1990年 | 15篇 |
1989年 | 46篇 |
1988年 | 36篇 |
1987年 | 32篇 |
1986年 | 43篇 |
1985年 | 25篇 |
1984年 | 19篇 |
1983年 | 17篇 |
1982年 | 16篇 |
1981年 | 24篇 |
1980年 | 20篇 |
1979年 | 18篇 |
1978年 | 19篇 |
1977年 | 21篇 |
1976年 | 22篇 |
1975年 | 23篇 |
1974年 | 18篇 |
1973年 | 14篇 |
1971年 | 19篇 |
1970年 | 16篇 |
1969年 | 9篇 |
排序方式: 共有1634条查询结果,搜索用时 23 毫秒
21.
22.
23.
24.
Potential cancer therapy with the fragile histidine triad gene: review of the preclinical studies. 总被引:9,自引:0,他引:9
CONTEXT: The fragile histidine triad gene (FHIT) encompasses a human common fragile site, FRA3B, that is susceptible to environmental carcinogens. Deletion and inactivation of FHIT have been seen in a number of human premalignant and malignant lesions. OBJECTIVE: To review and evaluate preclinical studies of cancer therapy using the FHIT tumor suppressor gene and related studies involving Fhit protein expression. DATA SOURCES: A MEDLINE search of articles published from 1996 to June 2001 was performed; article reference lists were used to retrieve additional relevant articles. STUDY SELECTION: Immunohistochemical studies of primary tumors or relevant lesions were selected to evaluate Fhit expression in premalignant or malignant stages. Preclinical studies on antitumorigenic or therapeutic introduction of FHIT were reviewed for the effects of exogenous Fhit expression. For the immunohistochemical analyses, 26 studies were included that analyzed at least 15 cases of a single type of tumor. For precancerous lesions, 9 studies were included that analyzed at least 4 cases. For studies of FHIT introduction, 9 published studies were included. DATA EXTRACTION: Using primary data from each of the studies, we assessed the rationale and potential contribution of FHIT cancer therapy. Data was independently abstracted by 2 authors and study quality was assessed by 2 other authors. DATA SYNTHESIS: Overall, 60% (1162/1948 cases) of primary tumors showed absent or markedly reduced Fhit protein expression in cancer cells. Studies of preneoplastic lesions or early-stage cancer showed absence or marked reduction of Fhit protein expression in 0% to 93% of samples (overall, 31% [127/408 cases]). Preclinical studies using 26 cancer-derived cell lines from human lung, head and neck, esophageal, gastric, cervical, pancreatic, and kidney cancers, showed that reintroduction of FHIT resulted in inhibition of in vitro tumor cell growth or of in vivo tumorigenicity in 17 (57%) of 30 cell line experiments. Model systems for human preventive cancer therapy suggested that oral introduction of viral vector-mediated FHIT into Fhit-deficient mice may prevent carcinogen-induced tumor development in some cases. CONCLUSION: These findings show that FHIT gene therapy may potentially be clinically useful for treatment of cancer and also prevention of carcinogen-induced tumor development, suggesting a rationale for further research involving FHIT introduction. 相似文献
25.
26.
Siconolfi Daniel Storholm Erik D. Vincent Wilson Pollack Lance Rebchook Gregory M. Huebner David M. Peterson John L. Kegeles Susan M. 《Archives of sexual behavior》2021,50(8):3621-3636
Archives of Sexual Behavior - Men who have sex with men (MSM) experience high prevalence of sexual violence (SV), and SV has well-documented effects on health. Research gaps are especially evident... 相似文献
27.
FHITness and cancer 总被引:3,自引:0,他引:3
In early 1996, the Fragile Histidine Triad or FHIT gene (pronounced FIT) was cloned and shown to straddle the most fragile human chromosome site at chromosome band 3p14.2. The exceptionally large FHIT locus also encompasses a hereditary renal carcinoma associated chromosome translocation breakpoint and is very frequently altered by internal deletions in the most common human cancers. Germline alteration of one allele in familial cancer and deletions within the gene in sporadic cancers are hallmarks of tumor suppressor genes. Some of the DNA and RNA alterations exhibited by the FHIT gene in cancers showed features not previously encountered for known tumor suppressor genes, prompting a number of investigators to reject FHIT as a suppressor gene. However, evidence continues to accumulate, demonstrating that FHIT inactivation occurs in the majority of lung, gastric, cervical, and kidney carcinomas and that replacement of Fhit expression in such cancer cells suppresses their tumorigenicity. 相似文献
28.
Congenital pulmonary atresia with ventricular septal defect: angiographic and surgical correlates 总被引:1,自引:0,他引:1
Of 181 patients with severe congenital pulmonary atresia and ventricular septal defect or "type IV truncus" (an obsolete term), all but 11% had true central pulmonary arteries. These arteries were demonstrable by large serial biplane angiograms using multiple selective injections into collateral vessels, frequent photographic subtraction, and occasional pulmonary vein-wedge angiograms. These techniques are extremely important for accurate diagnosis and in planning corrective or palliative surgery, which was done in 77% of patients with pulmonary arteries. 相似文献
29.
30.
OBJECTIVES: To investigate maternal knowledge and attitudes about otitis media (OM) risk, to estimate the prevalence of risk factors in the first year of life, and to identify barriers to the reduction of risk factors (eg, formula feeding, day care attendance, and exposure to passive smoke). METHODS: Questionnaires mailed to a systematic sample of 504 Minnesota women >/=18 years old identified through 1994 birth certificates. RESULTS: Eighty percent returned a completed survey. According to maternal report, 29% of infants (age 8 to 13 months) had recurrent OM (>/=3 episodes) and 2% had tympanostomy tubes. Forty-six percent attended day care, 29% had >/=1 smoking parent, and 49% breastfed for =2 months. Women were more knowledgeable about OM signs and symptoms than about risk factors. Mean OM knowledge score (the sum of correct true-false responses) was 7.0 (standard deviation = 1.6). Using multiple linear regression, knowledge score was significantly related to marital status, education, age, area of residence, breastfeeding (months), and number of cigarettes smoked per day by the mother, but not to infant or sibling OM history or day care attendance (R = .23). Infant history of OM (odds ratio, 1.9; 95% confidence interval, 1.1 to 3.2) and white race (odds ratio, 0.3; 95% confidence interval, 0. 1 to 0.8), but not the presence of risk factors, were significantly related to having received clinicians' advice about OM prevention advice. CONCLUSION: OM education and prevention programs should target pregnant women and new mothers with OM risk factors, and those who are young, single, and less educated. 相似文献